logo
As work continues to clear Milwaukee Public Schools of lead hazards, Starms Early Childhood Center gets a green light

As work continues to clear Milwaukee Public Schools of lead hazards, Starms Early Childhood Center gets a green light

Yahoo22-05-2025

As Milwaukee Public Schools works to repair lead paint hazards at buildings citywide, it announced May 21 that Starms Early Childhood Center is clean and safe.
'The MPS facilities team is making good progress in clearing schools of lead dangers,' MPS Superintendent Brenda Cassellius said in a statement. 'Our students and families have navigated these disruptions with patience, and for that we are grateful. I'm encouraged that we have been able to clear another building of lead dangers and that there is a clear plan moving forward for all our schools.'
Students have been displaced from the building since March 17 — over 10 weeks — in response to lead issues. The building was built in 1893.
They moved to the nearby, but separate, Starms Discovery Learning Center.
"While the building is now ready for occupancy, the school community has asked to remain at the Starms Discovery Learning Center building for the remainder of this school year to limit disruptions to teaching and learning," the district said in a statement.
According to a visual inspection report, inspectors found lead dust hazards on floors, horizonal surfaces within kids' reach and class supplies at Starms Early Childhood Center. Chipping and peeling paint was present in classrooms for kids with disabilities, and areas where kids 6 years and younger learn.
Between 10% and 50% of paint in the building was in decay, the inspection report said.
Starms Early Childhood Center was a top-priority school for lead work, according to a spreadsheet of schools included as part of MPS' Lead Action Plan.
MPS said it's weighing several factors when deciding which schools should be remediated first: building age and condition, student population, whether any cases of lead poisoning are associated with the school, and the prevalence of childhood lead poisoning cases in the school neighborhood.
As of May 13, MPS said it had inspected 48 schools for lead hazards. The district's lead plan said it will assess 107 schools and correct the issues identified.
Starms is among six schools that have closed temporarily this school year due to lead hazards. Those schools together educate about 1,800 kids, 2024-25 state data shows.
Students and staff at Brown Street Academy, Westside Academy and LaFollette Elementary School are still displaced as their schools undergo lead remediation. Trowbridge School of Great Lakes Studies and Fernwood Montessori both closed temporarily but have since reopened.
More: Milwaukee Public Schools says 48 schools already inspected for lead hazards, with more to come
Cleo Krejci covers K-12 education and workforce development as a Report For America corps member based at the Milwaukee Journal Sentinel. Contact her at CKrejci@gannett.com or follow her on Twitter @_CleoKrejci. For more information about Report for America, visit jsonline.com/rfa.
This article originally appeared on Milwaukee Journal Sentinel: An MPS school built in 1893 cleared of lead hazards, district says

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GPs Voice Top 10 AI Concerns
GPs Voice Top 10 AI Concerns

Medscape

time30-05-2025

  • Medscape

GPs Voice Top 10 AI Concerns

A review of queries received by the Medical Protection Society (MPS) last year has highlighted the top concerns of GPs about the growing use of artificial intelligence (AI) in medical practice. The MPS told Medscape News UK that all AI-themed queries came from GPs. No questions were raised by secondary care doctors. Key Concerns Identified The assessment revealed 10 main areas of concern for GPs: Patient safety Data protection Patient consent Liability Indemnity Transcribing tools Generation of fit notes Clinical prompts Processing of laboratory results Generative AI GPs Wary of AI Risks Medicolegal advice on these themes has been published on the MPS website. "We know members are keen to explore and adopt AI tools, which may enhance patient care and help to facilitate more efficient working," Dr Ben White, MPS deputy medical director, said in a press release. However, calls to the medicolegal advice line showed members were wary of potential risks. Particular concerns included liability and defence society cover, safety for patients, data protection, and patient consent. Such concerns echo a survey by Medscape last year which found that one in five respondents were apprehensive about using AI in clinical practice. More specific advice was sought on the medicolegal implications of using AI software for transcribing patient consultations, generating fit-to-fly letters or fit notes, using clinical prompts, and processing laboratory results. "AI is of course fast-evolving, and we will continue to revisit the guidance," White said. The MPS Foundation has contributed to a white paper on AI in healthcare , aimed at ensuring AI tools are developed and integrated to be usable, useful, and safe for both patients and clinicians. "Bringing about greater confidence in AI among clinicians is vital if the potential benefits are to be unlocked," White said. Doctors Support AI But Remain Concerned Nell Thornton, improvement fellow at the Health Foundation, said the MPS findings echoed the foundation's own research. "If AI is to help fulfil its promise to improve patient care, further clarification is needed on issues like regulation and professional liability," she told Medscape News UK . Doctors are keen to ensure that the human dimension of care is protected in an increasingly digitised system, she added. "Addressing these issues will be crucial for ensuring the development and adoption of AI is responsible and works for everyone." Professor Kamila Hawthorne, chair of the Royal College of General Practitioners, told Medscape News UK that the college was "always open to introducing new technologies that can improve the experience of patients – and GPs are often at the forefront of this". However, AI use is "not without potential risks" and its implementation "must be closely regulated to guarantee patient safety and the security of their data". "Technology will always need to work alongside and complement the work of doctors and other healthcare professionals, and it can never be seen as a replacement for the expertise of a qualified medical professional," Hawthorne emphasised. "Clearly there is big potential for the use of AI in general practice, but it's vital that it is carefully implemented and closely regulated in the interest of patient safety." Consultation Summaries Show Promise and Peril Dr Rosie Shire from the Doctors' Association UK GP committee told Medscape News UK : "As more AI tools become available, the possibilities of how they could assist GPs grows, but so do the concerns, as highlighted by the MPS." The idea of AI software providing a summary of a GP consultation was "very appealing", she said. It could enable GPs to focus fully on the patient rather than taking notes, which could improve communication and patient satisfaction, and save time on recall and typing up notes. "However, it's vital software is accurate and reliable, able to distinguish who is speaking, and understands accents and dialects,' Shire stressed. 'Otherwise it could lead to increased workload, as GPs spend additional time checking the AI has performed correctly." AI Can't Replace 'Gut Feeling' There is potential for inaccuracies being introduced into patient records if clinicians become over-reliant on AI records of consultations, Shire said. In time-pressured clinics, GPs might not read through AI summaries. "It's important clinicians are given time to review and confirm any AI-generated outcome to ensure accuracy. We also need to remember that AI can't replace that gut feeling you occasionally get as a GP when you see a patient you know, and feel that something just isn't right,' she added. Liability Questions Remain Shire said that a standard policy on AI use in general practice was needed. Clarity is also required over who would be responsible if AI software malfunctioned and led to patient harm. "Would it be the practice partners, as the data owners, the GP who saw the patient, or the AI software provider?" White said the MPS would not normally provide indemnity for issues relating to AI software failure. While the society is not currently aware of any binding case law, "we would expect the designers or producers of the AI software to be liable for any issues relating to the failure of the AI software'. Where a practice has purchased an AI system, the individual GP using it would remain potentially liable for any harm that results from its use. "Doctors remain responsible for the decisions they make whilst using such technology,' he said. 'In order to mitigate the risk of a complaint or claim, doctors should assure themselves that any system they are using is fit for purpose and appropriate for the patients that they are seeing."

Global Summit on Microphysiological Systems Research Set to Shape the Future of Drug Development and Disease Modeling
Global Summit on Microphysiological Systems Research Set to Shape the Future of Drug Development and Disease Modeling

Business Wire

time22-05-2025

  • Business Wire

Global Summit on Microphysiological Systems Research Set to Shape the Future of Drug Development and Disease Modeling

BRUSSELS--(BUSINESS WIRE)--The 4th Annual MPS World Summit, hosted by the International MPS Society (IMPSS) and supported by EUROoCS, will take place in Brussels, Belgium this summer. This premier event will bring together over 1,500 global leaders in Microphysiological Systems (MPS) research, focusing on innovative applications in drug safety, disease modeling, and regulatory testing. It will showcase the latest breakthroughs and foster collaboration across multiple sectors of the biomedical and pharmaceutical industries. Microphysiological systems (MPS) are revolutionizing medical and pharmaceutical research. These systems replicate human biology in controlled environments, offering more accurate models for drug testing, disease understanding, and treatment development—saving lives and reducing animal testing. The Summit will provide a key platform to discuss these groundbreaking technologies and their role in advancing biomedical research and drug development. The MPS World Summit will feature scientific sessions, interactive roundtables, and panel discussions, offering attendees opportunities to engage with cutting-edge MPS technologies. Experts from top universities and institutions will share insights on MPS development, disease modeling, and regulatory testing, fostering collaboration and innovation across the biomedical and pharmaceutical sectors. This Summit is a must-attend event for professionals advancing personalized medicine and improving medical research. Lena Smirnova, President of iMPSS, emphasized the importance of the Summit: 'The 4th Annual MPS World Summit is our largest gathering to date, reflecting the growing global interest in MPS research. This growth aligns with the FDA's recent initiative to phase out animal testing requirements for monoclonal antibodies and other drugs, and NIH's announcement on prioritization of human-based research. This news emphasizes the prime time for MPS with the shift towards human-relevant testing methods. As we convene our global experts, this Summit highlights our collective commitment to advancing drug safety, disease modeling, and regulatory testing through cutting-edge technologies.' For additional information, visit About IMPSS The International MPS Society (IMPSS) is a non-profit organization committed to advancing Microphysiological Systems (MPS) through collaboration, research, and education. The MPS World Summit serves as the premier global platform for IMPSS to provide opportunities for MPS researchers and industry professionals to exchange knowledge and drive innovations in drug safety, disease modeling, and regulatory testing. Membership is open to researchers and others with an interest in MPS worldwide.

As work continues to clear Milwaukee Public Schools of lead hazards, Starms Early Childhood Center gets a green light
As work continues to clear Milwaukee Public Schools of lead hazards, Starms Early Childhood Center gets a green light

Yahoo

time22-05-2025

  • Yahoo

As work continues to clear Milwaukee Public Schools of lead hazards, Starms Early Childhood Center gets a green light

As Milwaukee Public Schools works to repair lead paint hazards at buildings citywide, it announced May 21 that Starms Early Childhood Center is clean and safe. 'The MPS facilities team is making good progress in clearing schools of lead dangers,' MPS Superintendent Brenda Cassellius said in a statement. 'Our students and families have navigated these disruptions with patience, and for that we are grateful. I'm encouraged that we have been able to clear another building of lead dangers and that there is a clear plan moving forward for all our schools.' Students have been displaced from the building since March 17 — over 10 weeks — in response to lead issues. The building was built in 1893. They moved to the nearby, but separate, Starms Discovery Learning Center. "While the building is now ready for occupancy, the school community has asked to remain at the Starms Discovery Learning Center building for the remainder of this school year to limit disruptions to teaching and learning," the district said in a statement. According to a visual inspection report, inspectors found lead dust hazards on floors, horizonal surfaces within kids' reach and class supplies at Starms Early Childhood Center. Chipping and peeling paint was present in classrooms for kids with disabilities, and areas where kids 6 years and younger learn. Between 10% and 50% of paint in the building was in decay, the inspection report said. Starms Early Childhood Center was a top-priority school for lead work, according to a spreadsheet of schools included as part of MPS' Lead Action Plan. MPS said it's weighing several factors when deciding which schools should be remediated first: building age and condition, student population, whether any cases of lead poisoning are associated with the school, and the prevalence of childhood lead poisoning cases in the school neighborhood. As of May 13, MPS said it had inspected 48 schools for lead hazards. The district's lead plan said it will assess 107 schools and correct the issues identified. Starms is among six schools that have closed temporarily this school year due to lead hazards. Those schools together educate about 1,800 kids, 2024-25 state data shows. Students and staff at Brown Street Academy, Westside Academy and LaFollette Elementary School are still displaced as their schools undergo lead remediation. Trowbridge School of Great Lakes Studies and Fernwood Montessori both closed temporarily but have since reopened. More: Milwaukee Public Schools says 48 schools already inspected for lead hazards, with more to come Cleo Krejci covers K-12 education and workforce development as a Report For America corps member based at the Milwaukee Journal Sentinel. Contact her at CKrejci@ or follow her on Twitter @_CleoKrejci. For more information about Report for America, visit This article originally appeared on Milwaukee Journal Sentinel: An MPS school built in 1893 cleared of lead hazards, district says

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store